|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
4R37AI033493-15
|
|
Mechanisms of Gonococcal Pilin Antigenic & Phase Variation
|
SEIFERT, H.
|
NORTHWESTERN UNIVERSITY
|
IL
|
$377,500
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5R34MH075628-03
|
|
Preventing HIV & Drug Use Among Juvenile Offenders
|
DONENBERG, GERI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$228,311
|
|
Sexually Transmitted Diseases/Herpes
|
NIAAA
|
5F31AA016705-02
|
|
Contextualizing Young Women's Experiences of Alcohol and Sexual Risk
|
WELLS, BROOKE
|
CUNY GRADUATE SCH AND UNIV CTR
|
NY
|
$16,055
|
|
Sexually Transmitted Diseases/Herpes
|
NINR
|
5F31NR008964-04
|
|
Partner-type Influence on Condom Use in Adolescent Girls
|
NELSON, LARON
|
UNIVERSITY OF ROCHESTER
|
NY
|
$14,584
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI057552-04
|
|
International Herpes Vaccine Project
|
KNIPE, DAVID
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$394,157
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI054359-05
|
|
Immune Induction to Genital Herpes Simplex Virus 2
|
IWASAKI, AKIKO
|
YALE UNIVERSITY
|
CT
|
$266,144
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI062755-04
|
|
Sexually Transmitted Infections & Antimicrobial Peptides
|
SHAFER, WILLIAM
|
EMORY UNIVERSITY
|
GA
|
$318,814
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI060836-03
|
|
Herpes Simplex Virus Capsid Assembly and DNA Packaging
|
HOMA, FREDERICK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$318,271
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI044821-09
|
|
Repression and Activation of Persisting HSV Genomes
|
DELUCA, NEAL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$304,301
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5R01MH065849-05
|
|
Intervention for Female Workers in Mexico
|
PATTERSON, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$746,976
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA081310-07
|
|
Effect of Oxidant Load on HPV Persistence and CIN (SIL)
|
GIULIANO, ANNA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$459,600
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI059650-05
|
|
Host response to Chlamydia genital infection in the male
|
RANK, ROGER
|
ARKANSAS CHILDREN'S HOSPITAL RES INST
|
AR
|
$332,534
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
1R01DA024864-01
|
|
Drug Use and Other Risk Factors for HIV Infection in Female Sex Workers in China
|
WANG, NING
|
NATIONAL CENTER/AIDS/STD CONTROL/PREVENT
|
CHINA
|
$93,223
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI064705-03
|
|
Viral recognition by plasmacytoid dendritic cell
|
IWASAKI, AKIKO
|
YALE UNIVERSITY
|
CT
|
$389,355
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5R34MH078719-02
|
|
Reducing Teen Risky Behavior: A Clinic-Based Approach
|
GUILAMO-RAMOS, VINCENT
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$289,800
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
1R13AI075924-01
|
|
2008 Spirochetes Gordon Research Conference
|
HAAKE, DAVID
|
GORDON RESEARCH CONFERENCES
|
RI
|
$15,000
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA120847-02
|
|
Role of Estrogen in Cervical Cancer
|
LAMBERT, PAUL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$276,442
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI044033-08
|
|
Molecular Genetic Analysis of Chlamydia Pathogenicity
|
MAURELLI, ANTHONY
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$288,623
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI059384-02
|
|
Human Immune Response to Haemophilus Ducreyi Infection
|
SPINOLA, STANLEY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$369,805
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI064537-04
|
|
Chlamydia trachomatis proteomics
|
ZHONG, GUANGMING
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$339,510
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI061628-03
|
|
The Role of Uncultivated Bacteria in Bacterial Vaginosis
|
FREDRICKS, DAVID
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$570,275
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
1R01MH086160-01
|
|
Adolescent Women & microbicide Trials: Assessing the Challenges and Opportunities
|
TOLLEY, ELIZABETH
|
FAMILY HEALTH INTERNATIONAL
|
NC
|
$409,591
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
4R37CA078766-11
|
|
Dissection of the Functions of Herpes Simplex Virus ICPO
|
ROIZMAN, BERNARD
|
UNIVERSITY OF CHICAGO
|
IL
|
$382,057
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI055869-04
|
|
Analyses of sigma factor 28 of C. trachomatis
|
SHEN, LI
|
BOSTON MEDICAL CENTER
|
MA
|
$47,513
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI069136-03
|
|
Role of viral and cellular recombination proteins in HSV DNA replication
|
WELLER, SANDRA
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$281,955
|
|
Sexually Transmitted Diseases/Herpes
|
NINR
|
1R41NR010753-01
|
|
A low-cost point-of-care diagnostic test for simultaneous HIV-1 & STI
|
SIA, SAMUEL
|
INFOSCITEX CORPORATION
|
MA
|
$117,489
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI068107-03
|
|
A community-level RCT of expedited partner treatment for gonorrhea and chlamydia
|
GOLDEN, MATTHEW
|
UNIVERSITY OF WASHINGTON
|
WA
|
$592,031
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R37AI032011-16
|
|
Haemophilus ducreyi Inhibits Phagocytosis
|
HANSEN, ERIC
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$373,877
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI057450-03
|
|
Chlamydial Manipulation of Host Apoptosis
|
ZHONG, GUANGMING
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$312,913
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
2P30DA011041-11
|
9012
|
DISSEMINATION CORE
|
OSBORNE, ANDREW
|
NATIONAL DEVELOPMENT & RES INSTITUTES
|
NY
|
$181,473
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI062827-03
|
|
Genetics of Host Resistance to Chlamydia trachomatis
|
STARNBACH, MICHAEL
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$403,644
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA081135-10
|
|
Modulation of Host Cell Apoptotic Responses by HPVE7
|
MUNGER, KARL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$282,084
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA083939-09
|
|
FUNCTIONS FOR HERPES SIMPLEX VIRUS ICP22 AND US1.5
|
ROIZMAN, BERNARD
|
UNIVERSITY OF CHICAGO
|
IL
|
$492,652
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI044239-09
|
|
Molecular genetics of the gonococcus
|
SEIFERT, H.
|
NORTHWESTERN UNIVERSITY
|
IL
|
$276,259
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI055977-05
|
|
Gonococcal Pilus Structure and Function
|
SEIFERT, H.
|
NORTHWESTERN UNIVERSITY
|
IL
|
$276,259
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI050050-07
|
|
Structural Specificity of Heparan Sulfate for Herpes Infections
|
LIU, JIAN
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$280,676
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI042815-10
|
|
Protection of Genital Mucosa and Ganglia Against HSV-2
|
MILLIGAN, GREGG
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$245,796
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI016692-28
|
|
Membrane Proteins of Treponema pallidum
|
NORGARD, MICHAEL
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$492,082
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
7R01AI060038-03
|
|
CNS PATHOLOGY AFTER HSV INFECTION IS IMMUNE CELL-MEDIATED
|
LUNDBERG, PATRIC
|
EASTERN VIRGINIA MEDICAL SCHOOL
|
VA
|
$341,728
|
|
Sexually Transmitted Diseases/Herpes
|
NIDCR
|
5R01DE017315-03
|
|
Mouse Model for Human Papillomaviral (HPV)-associated Oral Cancer
|
LAMBERT, PAUL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$328,052
|
|
Sexually Transmitted Diseases/Herpes
|
NINDS
|
5K08NS048150-04
|
|
Pathogenesis of pseudorabies virus (PRV):
|
REYNOLDS, ASHLEY
|
PRINCETON UNIVERSITY
|
NJ
|
$134,335
|
|
Sexually Transmitted Diseases/Herpes
|
NEI
|
5R01EY005945-22
|
|
Cytotoxic Lymphocytes and HSV-1 Corneal Lesions
|
HENDRICKS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$340,955
|
|
Sexually Transmitted Diseases/Herpes
|
NEI
|
5R01EY009171-14
|
|
Ocular Disposition of Antimicrobial Agents
|
MITRA, ASHIM
|
UNIVERSITY OF MISSOURI KANSAS CITY
|
MO
|
$294,609
|
|
Sexually Transmitted Diseases/Herpes
|
FIC
|
1K01TW008016-01
|
|
Conditional Cash Transfers to Prevent Sexually Transmitted Infections in Mexico
|
GALARRAGA, OMAR
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$119,241
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5R01MH077541-02
|
|
High-risk Establishments and Women's HIV Prevention in Southern China
|
WEEKS, MARGARET
|
INSTITUTE FOR COMMUNITY RESEARCH
|
CT
|
$464,406
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI060892-05
|
|
Douching Prevention Trial in Mother-Daughter Dyads
|
ROMPALO, ANNE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$474,813
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI063365-03
|
|
T regulatory Cells in HSV Immunity and Immunopathology
|
ROUSE, BARRY
|
UNIVERSITY OF TENNESSEE KNOXVILLE
|
TN
|
$341,670
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI037549-13
|
|
HSV 1 Processing/Packaging Genes
|
WELLER, SANDRA
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$315,965
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI056045-05
|
|
HSV-Receptor Interaction in Entry and Pathogenesis
|
EISENBERG, ROSELYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$368,577
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA068782-22
|
|
Antiviral Actions of Interferons
|
SEN, GANES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$428,839
|
|
Sexually Transmitted Diseases/Herpes
|
FIC
|
1R03TW007754-01A1
|
|
Pathogenesis of persistent C. trachomatis STDs
|
DEAN, DEBORAH
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
CA
|
$39,728
|
|
Sexually Transmitted Diseases/Herpes
|
FIC
|
1R03TW008023-01
|
|
Systemic Innate Immune Responses in Secondary Syphilis
|
SALAZAR, JUAN
|
CONNECTICUT CHILDREN'S MEDICAL CENTER
|
CT
|
$39,380
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R21AI072400-02
|
|
RNAi screen to identify host factors involved in Chlamydia pathogenesis
|
DERRE, ISABELLE
|
YALE UNIVERSITY
|
CT
|
$202,689
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA076183-06
|
|
Targeting diffuse liver metastases with Herpes virus
|
TANABE, KENNETH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$375,113
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI057860-04
|
|
Molecular Mechanism of HSV Entry and Spread
|
SHUKLA, DEEPAK
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$284,468
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI056346-05
|
|
Alpha-Herpesvirus Transport in Axons
|
SMITH, GREGORY
|
NORTHWESTERN UNIVERSITY
|
IL
|
$276,259
|
|
Sexually Transmitted Diseases/Herpes
|
NIDCR
|
5R01DE016406-04
|
|
Genomic and Proteomic Analysis of HPV-Associated SCCHN
|
KHAN, SALEEM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$343,062
|
|
Sexually Transmitted Diseases/Herpes
|
NEI
|
5R01EY007336-18
|
|
Virus specific factors of HSV to corneal disease
|
BRANDT, CURTIS
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$270,098
|
|
Sexually Transmitted Diseases/Herpes
|
NIBIB
|
5R01EB002100-04
|
|
Applications of TiO2-DNA nanocomposites
|
WOLOSCHAK, GAYLE
|
NORTHWESTERN UNIVERSITY
|
IL
|
$283,791
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI063106-26
|
|
Genetics of Herpesvirus Transformation
|
KNIPE, DAVID
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$354,743
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI046613-09
|
|
Innate Immune Receptors in Host Responses to Neisseria
|
INGALLS, ROBIN
|
BOSTON MEDICAL CENTER
|
MA
|
$311,747
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI062428-04
|
|
Antiviral CTL mobilization to the genital mucosa
|
IWASAKI, AKIKO
|
YALE UNIVERSITY
|
CT
|
$380,205
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5F32AI065091-03
|
|
Role of PilQ in the function of the gonococcal pilus
|
HELM, R
|
NORTHWESTERN UNIVERSITY
|
IL
|
$53,992
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R21AI065308-02
|
|
Murine Model of Sexually Transmitted Disease-enhanced HIV Transmission
|
SPEAR, GREGORY
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$217,782
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI048073-08
|
|
Anti-herpesvirus Signaling by LTalphabeta/LIGHT Cytokines
|
WARE, CARL
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$440,040
|
|
Sexually Transmitted Diseases/Herpes
|
NLM
|
5G13LM009227-02
|
|
Testifying on Tuskegee: Telling the Tuskegee Syphilis Study Stories
|
REVERBY, SUSAN
|
WELLESLEY COLLEGE
|
MA
|
$70,887
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R21CA124324-02
|
|
Methylation and Related Anogenital HPV Cancers
|
WILEY, DOROTHY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$185,374
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5U10MH064394-07
|
|
HIV/STD Risk Reduction for African American Couples
|
JEMMOTT, JOHN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$605,217
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5U10MH064395-07
|
|
HIV/AIDS Risk Reduction for African American Couples
|
EL-BASSEL, NABILA
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$991,700
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5U10MH064404-07
|
|
NIMH Multisite HIV/STD Prevention Trial for African-American Couples
|
WYATT, GAIL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$676,691
|
|
Sexually Transmitted Diseases/Herpes
|
NINDS
|
5R37NS033506-14
|
|
Genetic Analysis of Herpesvirus Tropism and Virulence
|
ENQUIST, LYNN
|
PRINCETON UNIVERSITY
|
NJ
|
$338,132
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R43AI072800-02
|
|
Rapid DNA Assay System for Characterization of Infectious Disease Pathogens
|
WHITE, ROBERT
|
MAGARRAY, INC.
|
CA
|
$296,693
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5U10MH064393-07
|
|
NIMH Multisite HIV/STD Prevention Trial for African-American Couples
|
WINGOOD, GINA
|
EMORY UNIVERSITY
|
GA
|
$1,041,927
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
5R01HD041731-08
|
|
Gender, power, and susceptibility to STDs/HIV in India
|
KRISHNAN, SUNEETA
|
RESEARCH TRIANGLE INSTITUTE
|
NC
|
$571,814
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
1R03DA024088-01
|
|
Neighborhood Context, Drug Use, and Risky Sexual Behavior Among U.S. Adolescents
|
EDWARDS, JESSICA
|
PACIFIC INSTITUTE FOR RES AND EVALUATION
|
MD
|
$77,871
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA117830-03
|
|
Chromatin Dynamics of KSHV Latency
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
PA
|
$283,108
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R01DA018061-04
|
|
The HIV Risk Behavior and the Urban Environment
|
VLAHOV, DAVID
|
NEW YORK ACADEMY OF MEDICINE
|
NY
|
$589,669
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R37AI038382-14
|
|
HPV CAPSID ANTIBODIES
|
GALLOWAY, DENISE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$316,257
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
1K01HD057246-01
|
|
Predicting Impacts of Infectious Disease on Structure and Dynamics of Populations
|
CLARK, SAMUEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$118,724
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
1K08CA131171-01
|
|
Regulation of Telomerase by NFX1
|
KATZENELLENBOGEN, RACHEL
|
CHILDREN'S HOSPITAL AND REG MEDICAL CTR
|
WA
|
$134,379
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R21CA114978-02
|
|
A Therapeutic Vaccine for HPV 16-Positive Head and Neck Cancer
|
GILLISON, MAURA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$265,009
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
1K23AI076670-01
|
|
Cervical Maturity, Mucosal Immunity, and Chlamydia trachomatis infection
|
HWANG, LORIS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$124,200
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI041478-08
|
|
UL34 and herpes simplex virus envelopment
|
ROLLER, RICHARD
|
UNIVERSITY OF IOWA
|
IA
|
$245,877
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA107338-05
|
|
Mechanisms of HPV DNA Segregation
|
CHOW, LOUISE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$348,630
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA116720-03
|
|
Mechanistic Analysis of Papillimavirus E2 Functions
|
HOWLEY, PETER
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$262,923
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA021776-31
|
|
Herpesvirus gene expression in transformed cells
|
SPEAR, PATRICIA
|
NORTHWESTERN UNIVERSITY
|
IL
|
$261,514
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA114425-04
|
|
ENHANCING HPV-16 E6-SPECIFIC ANTITUMOR IMMUNITY
|
WU, T.-C.
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$307,116
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA064795-14
|
|
Interactions of HPV Oncogenes With the p53 Pathway
|
GALLOWAY, DENISE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$548,928
|
|
Sexually Transmitted Diseases/Herpes
|
NINR
|
5R01NR008194-05
|
|
Maintaining HIV Prevention Gains in Female Adolescents
|
MORRISON-BEEDY, DIANNE
|
UNIVERSITY OF ROCHESTER
|
NY
|
$614,302
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
1K99DA024135-01
|
|
Epidemiology of Syphilis among IDUs in Tijuana, Mexico
|
RUSCH, MELANIE
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$90,000
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R21AI064444-02
|
|
Archaeal gene recruitment by the Chlamydiales
|
GRAHAM, DAVID
|
UNIVERSITY OF TEXAS AUSTIN
|
TX
|
$182,084
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI043000-08
|
|
Genetics and Functions of HSV Membrane Fusion Proteins
|
KOUSOULAS, KONSTANTIN
|
LOUISIANA STATE UNIV A&M COL BATON ROUGE
|
LA
|
$307,653
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI072728-02
|
|
Ureaplasmas in acute and persistent urethritis: clinical implications
|
MANHART, LISA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$376,399
|
|
Sexually Transmitted Diseases/Herpes
|
NIGMS
|
5R01GM066861-06
|
|
Molecular Targets in Peptidoglycan Synthesis
|
DAVIES, CHRISTOPHER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$292,184
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA107394-05
|
|
Functions of Human Papillomavirus E6
|
ANDROPHY, ELLIOT
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$310,653
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA112512-04
|
|
Immunogenetics of Cervical and Vulvar Cancer
|
SCHWARTZ, STEPHEN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$607,277
|
|
Sexually Transmitted Diseases/Herpes
|
NEI
|
2R01EY010359-14A1
|
|
Cytokines and Adhesion Molecules in HSV Keratitis
|
HENDRICKS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$508,383
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI063928-04
|
|
Gamma-2 Herpesviruses as Vaccine Vectors for AIDS
|
DESROSIERS, RONALD
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$498,084
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA105181-04
|
|
Natural History of HPV Infections in Men
|
KOUTSKY, LAURA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$652,646
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA111196-03
|
|
MODULATION OF ONCOGENIC AGENTS BY MARIJUANA
|
MEDVECZKY, PETER
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$224,920
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI042737-10
|
|
Molecular Characterization of Herpes Simplex Virus ICP27
|
RICE, STEPHEN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$228,804
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
1R21MH082421-01
|
|
HSV amplicon vectors for neuroscience research
|
CHIOCCA, E. ANTONIO
|
OHIO STATE UNIVERSITY
|
OH
|
$202,500
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
1R01AI070693-01A2
|
|
Transcriptional Control of Chlamydial Development
|
BELLAND, ROBERT
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$365,000
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
2R01AI048611-06A2
|
|
The Gonococcal Fur Regulon: Link to Pathogenesis
|
GENCO, CAROLINE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$365,625
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA108641-03
|
|
Role of Wnt signaling in Cervical Cancer Pathogenesis
|
UREN, AYKUT
|
GEORGETOWN UNIVERSITY
|
DC
|
$267,492
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI065605-02
|
|
Risk Factors and Susceptibility in Gonococcal Infection
|
GRIFFISS, JOHN
|
NORTHERN CALIFORNIA INSTITUTE RES & EDUC
|
CA
|
$373,128
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI061679-05
|
|
Role of Calcium Signaling in HSV-2 Invasion
|
HEROLD, BETSY
|
YESHIVA UNIVERSITY
|
NY
|
$347,418
|
|
Sexually Transmitted Diseases/Herpes
|
NEI
|
2R01EY013168-08
|
|
Ocular HSV Infection-Latency and Pathogenesis
|
THOMPSON, RICHARD
|
UNIVERSITY OF CINCINNATI
|
OH
|
$395,906
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI059603-04
|
|
Gamma-herpesvirus infection of dendritic cells
|
FLANO, EMILIO
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$264,167
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
1R01AI073831-01A1
|
|
The Role of Rab GTPases in Chlamydia-Infected Cells
|
SCIDMORE, MARCI
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$377,615
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
2R01AI047958-05A2
|
|
Type IV secretion by Neisseria gonorrhoeae
|
DILLARD, JOSEPH
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$356,220
|
|
Sexually Transmitted Diseases/Herpes
|
NEI
|
1R01EY018171-01A1
|
|
Corneal HSV-1: Immunopathologic Mechanisms of HSK
|
WECHSLER, STEVEN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$381,250
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI047141-08
|
|
A Molecular Study of the Gonococcal Transferrin Receptor
|
CORNELISSEN, CYNTHIA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$316,472
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5K02AI057563-05
|
|
Molecular mechanisms of gene regulation in Chlamydia
|
TAN, MING
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$94,769
|
|
Sexually Transmitted Diseases/Herpes
|
NIGMS
|
2R01GM031318-45A1
|
|
ROBBINS Glycosylation and Glycosidases-Cell and Molecular Biology
|
ROBBINS, PHILLIPS
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$406,250
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
2R01AI026756-20A1
|
|
Treponema pallidum Outer Membrane Proteins and Transition Metal Acquisition
|
RADOLF, JUSTIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$480,083
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI021501-22
|
|
Control of mRNA Stability in HSV Infected Cells
|
READ, G.
|
UNIVERSITY OF MISSOURI KANSAS CITY
|
MO
|
$237,537
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI048626-08
|
|
Modulation of cell signaling pathways by alphaherpesvirus tegument components
|
BANFIELD, BRUCE
|
QUEEN'S UNIVERSITY AT KINGSTON
|
CANADA
|
$211,896
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA116316-03
|
|
Role and Regulation of the Human DEK Proto-Oncogene
|
WELLS, SUSANNE
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$258,530
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI043456-09
|
|
Surface Antigens of Treponema pallidum
|
VAN VOORHIS, WESLEY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$317,281
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI065309-05
|
|
Antimicrobial Peptides, Genital HSV & HIV Co-Infection
|
HEROLD, BETSY
|
YESHIVA UNIVERSITY
|
NY
|
$328,391
|
|
Sexually Transmitted Diseases/Herpes
|
NEI
|
9R01EY018755-11
|
|
Herpes simplex virus egress from cells and spread in neuronal axons
|
JOHNSON, DAVID
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$438,358
|
|
Sexually Transmitted Diseases/Herpes
|
NIDCR
|
5R01DE015944-05
|
|
Transcripitonal and Genetic Profiles in HNSCCs
|
SMITH, ELAINE
|
UNIVERSITY OF IOWA
|
IA
|
$281,653
|
|
Sexually Transmitted Diseases/Herpes
|
NIDCD
|
1R01DC008841-01A1
|
|
Genetic Susceptibility to Papilloma-induced Voice Disturbance
|
BUCHINSKY, FARREL
|
ALLEGHENY-SINGER RESEARCH INSTITUTE
|
PA
|
$524,629
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5F31AI068621-03
|
|
Characterization of gene expression in T. vaginalis
|
SMITH, ALIAS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$31,037
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI065530-04
|
|
Type III exported effectors of Chlamydia trachomatis
|
FIELDS, KENNETH
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$317,071
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI067888-02
|
|
Recombinant C. trachomatis vaccine
|
DE LA MAZA, LUIS
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$369,886
|
|
Sexually Transmitted Diseases/Herpes
|
NIGMS
|
1K25GM083395-01A2
|
|
How Feedback Circuitry Drives Phenotype Switching in a Human Herpesvirus
|
WEINBERGER, LEOR
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$124,200
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
1R03AI067569-01A2
|
|
Prophage-associated virulence factors in pathogenic Neisseria species
|
KARLS, ANNA
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$73,750
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
1R01AI073713-01A2
|
|
Behavioral and Virologic Impact of HPV Immunization
|
KAHN, JESSICA
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$537,672
|
|
Sexually Transmitted Diseases/Herpes
|
NIDCR
|
1R21DE017611-01A2
|
|
Treatment of oral cancer by herpes simplex virus
|
SHILLITOE, EDWARD
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$235,500
|
|
Sexually Transmitted Diseases/Herpes
|
NIGMS
|
5R01GM061139-08
|
|
Regulation of HSV Gene Expression by HCF
|
WILSON, ANGUS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$306,985
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5R34MH076648-03
|
|
Developing a Network Intervention to Promote Women's Health
|
CHOI, KYUNG-HEE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$119,829
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI068888-02
|
|
Role of LOS and Opa in gonococcal host interactions
|
STEIN, DANIEL
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$327,777
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
5K23HD047395-04
|
|
STDs, Cytokines, and Hormonal Contraception
|
GHANEM, KHALIL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$133,920
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI038383-14
|
|
Acquisition and Natural History of Genital HPV Infection
|
KOUTSKY, LAURA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$630,644
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI019782-22
|
|
Immunity and Latency to Chlamydial Infections
|
BYRNE, GERALD
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$344,697
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI013446-29
|
|
Virulence Factors of Chlamydiae
|
WYRICK, PRISCILLA
|
EAST TENNESSEE STATE UNIVERSITY
|
TN
|
$416,973
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI065892-02
|
|
Transcytosis of IgG in Genital Infections
|
ZHU, XIAOPING
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$254,937
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
1R03HD053590-01A1
|
|
Determinants and disparities in high-risk sexual behaviors in US adolescents
|
CARVAJAL, SCOTT
|
UNIVERSITY OF ARIZONA
|
AZ
|
$74,563
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R37AI027857-20
|
|
Biogenesis of Hydrogenosomes of a Trichomonad Parasite
|
JOHNSON, PATRICIA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$418,806
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI061382-03
|
|
Maturation functions of the HSV-1 tegument
|
DESAI, PRASHANT
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$312,436
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
2R01AI050189-06
|
|
gM/gN and envelopment of HCMV
|
BRITT, WILLIAM
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$326,250
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
1R21AI070772-01A2
|
|
Modulation of a novel cell cycle checkpoint by the HPV oncogene E6
|
CHEN, JASON
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$243,750
|
|
Sexually Transmitted Diseases/Herpes
|
NINDS
|
5R01NS026363-18
|
|
Injury-Induced Pain: Chemical Modulation of Nociceptors
|
RAJA, SRINIVASA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$308,646
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI064749-04
|
|
Interaction of Chalmydia with Innate Immune Receptors
|
INGALLS, ROBIN
|
BOSTON MEDICAL CENTER
|
MA
|
$299,513
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI064349-04
|
|
Innate Immunity and Herpes Simplex Pathogenesis
|
FINBERG, ROBERT
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$305,210
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI021150-23
|
|
Gonococci: Genetics of Resistance to PMN Proteins
|
SHAFER, WILLIAM
|
EMORY UNIVERSITY
|
GA
|
$365,023
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
2R01AI021747-24
|
|
Genetics of HSV DNA Replication
|
WELLER, SANDRA
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$524,946
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI040915-10
|
|
CHLAMYDIA TRACHOMATIS ENVELOPE COMPONENTS AND VIRULENCE
|
RAULSTON, JANE
|
EAST TENNESSEE STATE UNIVERSITY
|
TN
|
$339,510
|
|
Sexually Transmitted Diseases/Herpes
|
FIC
|
5R03TW007819-02
|
|
HPV and HTLV Infection in Female Sex Workers in Peru
|
ZUNT, JOSEPH
|
UNIVERSITY OF WASHINGTON
|
WA
|
$30,321
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R01DA017061-05
|
|
Brief Intervention to Reduce STDs in ER Drug Users
|
BERNSTEIN, EDWARD
|
BOSTON MEDICAL CENTER
|
MA
|
$462,119
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA104873-05
|
|
HPV helper functions for AAV Replication
|
HERMONAT, PAUL
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$227,407
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI047997-09
|
|
Chlamydial evasion of host immune recognition
|
ZHONG, GUANGMING
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$339,510
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R37AI032725-15
|
|
Immunology of Infection with Neisseria gonorrhoeae
|
RICE, PETER
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$549,530
|
|
Sexually Transmitted Diseases/Herpes
|
NINDS
|
5R01NS046006-05
|
|
Vaccination and microglia in Alzheimer's mouse models
|
HEPPNER, FRANK
|
CHARITE, UNIVERSITAETSMEDIZIN BERLIN
|
GERM
|
$165,766
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5R01MH079736-02
|
|
Help Us, Save Us! HIV/STI Prevention Intervention for High-Risk Black Men
|
JEMMOTT, JOHN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$711,006
|
|
Sexually Transmitted Diseases/Herpes
|
FIC
|
5D43TW007388-04
|
|
KEMRI-UCSF Infectious Disease Research Training Program
|
COHEN, CRAIG
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$141,717
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5R01MH077515-02
|
|
Experimental Analysis of HIV Risk Assessment Reactivity in South African Clinics
|
WEINHARDT, LANCE
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$555,450
|
|
Sexually Transmitted Diseases/Herpes
|
NIDCR
|
5R01DE015935-06
|
|
Study of genomic instability caused by HPV16 E6 and E7
|
MCCANCE, DENNIS
|
QUEEN'S UNIVERSITY BELFAST
|
UK
|
$249,199
|
|
Sexually Transmitted Diseases/Herpes
|
NIAMS
|
5R01AR042541-14
|
|
Reiter's syndrome mechanism of chlamydial pathogenesis
|
HUDSON, ALAN
|
WAYNE STATE UNIVERSITY
|
MI
|
$353,392
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
5R03HD052687-02
|
|
Ectopic Pregnancy: Assessing Long-Term Trends in Rates and Risk Factors
|
SCHOLES, DELIA
|
CENTER FOR HEALTH STUDIES
|
WA
|
$81,732
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
7R01AI065545-04
|
|
CHLAMYDIAL INVASION OF NON-PHAGOCYTIC CELLS
|
CARABEO, REYNALDO
|
IMPERIAL COLLEGE LONDON
|
UK
|
$226,954
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI053108-06
|
|
The Neuroimmunology of Viral Infection
|
CARR, DANIEL
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$279,097
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R41AI072847-02
|
|
Scanning Chlamydia proteome for vaccine antigens
|
DE LA MAZA, LUIS
|
IMMPORT THERAPEUTICS, INC.
|
CA
|
$299,255
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI073770-02
|
|
Novel approaches to identify host genes required for Chlamydia pathogenesis
|
ENGEL, JOANNE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$378,599
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5U01AI069551-05
|
|
Microbicide Effects on Efficacy, Safety, Innate Immunity
|
KELLER, MARLA
|
YESHIVA UNIVERSITY
|
NY
|
$429,277
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI071286-02
|
|
Analysis of the Herpes Simplex Virus Budding Mechanism
|
WILLS, JOHN
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$454,810
|
|
Sexually Transmitted Diseases/Herpes
|
NINDS
|
1F32NS056594-01A2
|
|
The Role of Us9 in Herpesvirus Neuroinvasion
|
LYMAN, MATHEW
|
PRINCETON UNIVERSITY
|
NJ
|
$24,998
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R01DA020130-03
|
|
Drug Abuse and Risky Sex in Borderline Personality
|
FESKE, ULRIKE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$334,177
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
5R21HD054451-02
|
|
Trichomonas Lipophosphoglycan in Regulation Immune Responses
|
FICHOROVA, RAINA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$162,680
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R41AI068159-02
|
|
Antiviral Compounds that Target HPV18 DNA
|
FISHER, CHRISTOPHER
|
NANOVIR, LLC.
|
MI
|
$498,425
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
1R21CA128232-01A1
|
|
Therapeutic HPV vaccination for stage IB1 cervical cancer
|
TRIMBLE, CORNELIA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$294,156
|
|
Sexually Transmitted Diseases/Herpes
|
NINDS
|
5K01NS049300-06
|
|
Multimodal replicative lytic viruses for glioma therapy
|
POST, DAWN
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$144,145
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R37AI042528-11
|
|
Cytotoxic T-Cell Responses to HSV: HIV-Infected Persons
|
COREY, LAWRENCE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$326,607
|
|
Sexually Transmitted Diseases/Herpes
|
NINDS
|
1F30NS061471-01
|
|
Maintenance of Herpes Simplex Type 1 Neuronal Latency by CD8 T cells
|
KNICKELBEIN, JARED
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$37,574
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5R21MH079827-02
|
|
Trabajando Juntos: Working for Health Disparity Reduction among Latinos
|
RHODES, SCOTT
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$159,591
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
5F31HD055957-02
|
|
Parenting and Adolescent Risky Sexual Behaviors
|
GERMAN, MIGUELINA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$33,816
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI057573-05
|
|
Functional analysis of HSV-2 tegument proteins in mice
|
MORRISON, LYNDA
|
SAINT LOUIS UNIVERSITY
|
MO
|
$273,469
|
|
Sexually Transmitted Diseases/Herpes
|
NIGMS
|
1F32GM083440-01
|
|
Probing the Universality and Function of Single dsDNA Viral Packaging Motors
|
TSAY, JAMES
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$46,826
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI036901-13
|
|
Mechanisms of antibiotic action in Neisseria gonorrhoeae.
|
NICHOLAS, ROBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$347,681
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI056359-15
|
|
Fidelity of Herpes Simplex Virus DNA Replication
|
HWANG, CHARLES
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$282,770
|
|
Sexually Transmitted Diseases/Herpes
|
NIDCR
|
5R01DE016631-04
|
|
Oral HPV Infection in HIV-Infected Men and Women
|
GILLISON, MAURA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$618,483
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R37AI036293-15
|
|
ENTRY OF HERPES SIMPLEX VIRUS INTO CELLS
|
SPEAR, PATRICIA
|
NORTHWESTERN UNIVERSITY
|
IL
|
$345,323
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI059647-05
|
|
C. trachomatis genomics, strain typing, and evolution
|
DEAN, DEBORAH
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
CA
|
$533,583
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI063927-04
|
|
Bacterial STI and Innate Immunity in HIV Susceptibility
|
JARVIS, GARY
|
NORTHERN CALIFORNIA INSTITUTE RES & EDUC
|
CA
|
$565,711
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
1F32AI072942-01A2
|
|
DNA Immunization in the Female Genital Tract Using A Controlled Delivery Matrix
|
BLUM, JEREMY
|
YALE UNIVERSITY
|
CT
|
$52,898
|
|
Sexually Transmitted Diseases/Herpes
|
FIC
|
5R01HD052429-02
|
|
Social and Contextual Predictors of Male Heterosexual HIV Risk Behavior in Africa
|
GUEST, GREGORY
|
FAMILY HEALTH INTERNATIONAL
|
NC
|
$2,000
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
5R01HD052429-02
|
|
Social and Contextual Predictors of Male Heterosexual HIV Risk Behavior in Africa
|
GUEST, GREGORY
|
FAMILY HEALTH INTERNATIONAL
|
NC
|
$467,004
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA118443-02
|
|
Etiologic Role of HPV in Keratinocyte Carcinomas
|
KARAGAS, MARGARET
|
DARTMOUTH COLLEGE
|
NH
|
$307,108
|
|
Sexually Transmitted Diseases/Herpes
|
NEI
|
5R01EY006012-24
|
|
Mechanisms of Herpes Simplex Virus Retinitis
|
ATHERTON, SALLY
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$306,182
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI033063-13
|
|
Herpes Simplex Virus FC Receptor
|
FRIEDMAN, HARVEY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$294,304
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA083679-09
|
|
Mechanisms of Human Papillomavirus DNA Replication
|
CHOW, LOUISE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$370,899
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI064634-02
|
|
Chromatin and Coactivators in HSV-1 gene regulation
|
TRIEZENBERG, STEVEN
|
VAN ANDEL RESEARCH INSTITUTE
|
MI
|
$357,084
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA037157-25
|
|
Cell Transformation by Bovine Papillomavirus
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
CT
|
$499,645
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5F31MH080625-02
|
|
The impact of incarceration on partner selection norms and HIV
|
GINDI, RENEE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$40,972
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA123467-02
|
|
HPV Infection Among Perimenopausal Women in the 1945-64 Birth Cohor
|
GRAVITT, PATTI
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$595,556
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA115662-04
|
|
Selective Degradation of mRNA by Herpes Simplex Virus 1
|
ROIZMAN, BERNARD
|
UNIVERSITY OF CHICAGO
|
IL
|
$312,207
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI068032-03
|
|
Chlamydia co-option of Eukaryotic Lipid Droplets
|
VALDIVIA, RAPHAEL
|
DUKE UNIVERSITY
|
NC
|
$334,345
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI061397-05
|
|
Domain structure and interactions of HSV-1 ICP27
|
SANDRI-GOLDIN, ROZANNE
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$363,125
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI049571-05
|
|
Characterization of Human T Cells Against Chlamydia
|
KAVATHAS, PAULA
|
YALE UNIVERSITY
|
CT
|
$342,186
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI039558-13
|
|
Cytotoxic T-cell Mediated Immunity to Chlamydia
|
STARNBACH, MICHAEL
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$512,231
|
|
Sexually Transmitted Diseases/Herpes
|
NIAAA
|
5K05AA015050-04
|
|
Substance Use and HIV Risk Behavior
|
LEIGH, BARBARA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$115,822
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
5R01HD036948-06
|
|
NSAM: Wave 4: HIV/STD Risk Trajectories
|
SONENSTEIN, FREYA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$465,348
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI051334-06
|
|
Extracellular Matrix Adhesins of Treponema pallidum
|
CAMERON, CAROLINE
|
UNIVERSITY OF VICTORIA
|
CANADA
|
$239,261
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R03CA128089-02
|
|
HPV in Heterosexual Couples
|
KORTE, JEFFREY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$73,000
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R01DA022953-03
|
|
Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study
|
TEPLIN, LINDA
|
NORTHWESTERN UNIVERSITY
|
IL
|
$1,132,219
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI070043-02
|
|
Statistical Methods to Study the Epidemiology of HIV & Other Disease
|
JEWELL, NICHOLAS
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$311,776
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
1R01HD053231-01A1
|
|
Relational and contextual phenomenology of STI/HIV risk
|
FORTENBERRY, J.
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$584,276
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI042143-11
|
|
Treponema pallidum:Pathogenesis-associated molecules
|
LUKEHART, SHEILA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$365,408
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA066980-13
|
|
Biological Activity of HPV E7 in Human Epithelial Cells
|
MUNGER, KARL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$373,348
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R13AI063796-05
|
|
Biennial Meeting of Chlamydia Basic Research Society
|
RANK, ROGER
|
CHLAMYDIA BASIC RESEARCH SOCIETY
|
AR
|
$1
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
1R21HD054326-01A2
|
|
Enhancing Delivery of Confidential Care and STI Screening in Urban Health Centers
|
MCKEE, MELISSA
|
YESHIVA UNIVERSITY
|
NY
|
$213,840
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
1R21HD055831-01A1
|
|
Sexual Aggression and HIV Risk in Young Heterosexual Men
|
PETERSON, ZOE
|
UNIVERSITY OF MISSOURI-ST. LOUIS
|
MO
|
$239,631
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
1R01DA023877-01A1
|
|
Epidemiologic Study on Changing HIV Risks Among FSW-IDUs on the Mexico-US Border
|
STRATHDEE, STEFFANIE
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$598,645
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5R01MH063008-07
|
|
HIV Prevention for Youth with Severe Mental Illness
|
BROWN, LARRY
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$628,924
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
2R42AI065015-02
|
|
Herpes Simplex Immunotherapeutic Vaccine
|
VILALTA, ADRIAN
|
VICAL, INC.
|
CA
|
$999,688
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
1R01DA022967-01A2
|
|
African American Female Drug Users: HIV, Health Disparities, & Criminality
|
OSER, CARRIE
|
UNIVERSITY OF KENTUCKY
|
KY
|
$574,039
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
1R01CA119904-01A2
|
|
Small Molecule Inhibitors of Oncogenic Human Papillomavirus
|
ANDROPHY, ELLIOT
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$354,628
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI072204-02
|
|
Cervical, Anal, and Oral HPV Persistence and Risk Factors Among Adolescent Girls
|
DIAZ, ANGELA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$818,235
|
|
Sexually Transmitted Diseases/Herpes
|
NIDCR
|
5R01DE018305-02
|
|
ART On Oral Tissue Growth, Function, and HPV Infections
|
MEYERS, CRAIG
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$344,677
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI060660-05
|
|
Purine Metabolism in Trichomonas vaginalis
|
WANG, C
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$281,840
|
|
Sexually Transmitted Diseases/Herpes
|
NCRR
|
5P40RR018604-05
|
|
Center for Neuroanatomy with Neurotropic Viruses
|
STRICK, PETER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$712,938
|
|
Sexually Transmitted Diseases/Herpes
|
NIMH
|
5P40RR018604-05
|
|
Center for Neuroanatomy with Neurotropic Viruses
|
STRICK, PETER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$185,844
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI042053-10
|
|
Gonococcal Infection and Gene Expression in Female Mice
|
JERSE, ANN
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$243,513
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5F32AI068297-03
|
|
Two way dialogue between GC and epithelial cells
|
KOZLOWICZ, BRIANA
|
UNIVERSITY OF ARIZONA
|
AZ
|
$50,428
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA111799-04
|
|
Cervical Cancer Prevention in Latina Immigrants
|
SCARINCI, ISABEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$166,948
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI067678-02
|
|
Molecular mechanisms of Chlamydia-induced Type 1 Interferon response
|
NAGARAJAN, UMA
|
ARKANSAS CHILDREN'S HOSPITAL RES INST
|
AR
|
$315,637
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R21CA124314-02
|
|
Human Papillomaviruses and the Tumor Microenvironment
|
ROMAN, ANN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$173,890
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5K23AI064396-04
|
|
HSV-2 shedding: role of hormonal contraception and BV
|
CHERPES, THOMAS
|
MAGEE-WOMEN'S RES INST AND FOUNDATION
|
PA
|
$126,630
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA115713-03
|
|
Chlamydia & Aberrant DNA Methylation in Cervical Cancer
|
KIVIAT, NANCY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$495,349
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA047622-17
|
|
Papillomavirus Host Interaction
|
CHRISTENSEN, NEIL
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$303,123
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA020260-33
|
|
Immediate Early Genes of Herpes Simplex Virus
|
SCHAFFER, PRISCILLA
|
UNIVERSITY OF ARIZONA
|
AZ
|
$387,594
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R01DA020366-03
|
|
Risk Reduction Intervention for Highly Vulnerable Emerging Adults Males
|
PARSONS, JEFFREY
|
HUNTER COLLEGE
|
NY
|
$523,480
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R01DA017612-04
|
|
Prevention among HIV+ Crack Users in the Hospital
|
METSCH, LISA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$693,614
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
4R37CA013202-37
|
|
Structure and Assembly of Viruses
|
HARRISON, STEPHEN
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$378,574
|
|
Sexually Transmitted Diseases/Herpes
|
NICHD
|
5R01HD045133-03
|
|
HIV/STD Prevention for High-Risk Youth in Liberia
|
KENNEDY, STEPHEN
|
PACIFIC INSTITUTE FOR RES AND EVALUATION
|
MD
|
$452,247
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R01DA022921-03
|
|
Partner-Specific HIV Risk Reduction for Drug Using Incarcerated Adolescents
|
ROSENGARD, CYNTHIA
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$279,197
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA103867-06
|
|
E2-Cellular Complexes in HPV Chromatin Transcription
|
CHIANG, CHENG-MING
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$274,654
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R37AI018289-27
|
|
Studies of Herpes Simplex Virus Glycoproteins
|
COHEN, GARY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$362,581
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI042927-11
|
|
T cell immunity to MHV 68, a murine gamma herpesvirus
|
BLACKMAN, MARCIA
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$325,558
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R01DA021115-03
|
|
Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
|
PATTERSON, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$584,639
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI048633-08
|
|
Molecular Genetics of HSV Reactivation
|
BLOOM, DAVID
|
UNIVERSITY OF FLORIDA
|
FL
|
$341,118
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA111187-04
|
|
HIV Associated DNA Hypermethylation in Cervical Cancer
|
KIVIAT, NANCY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$493,582
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R21DA022125-02
|
|
MSM Communities in NYC Respond to HIV and Methamphetamine
|
BRAINE, NAOMI
|
BETH ISRAEL MEDICAL CTR (NEW YORK)
|
NY
|
$191,222
|
|
Sexually Transmitted Diseases/Herpes
|
NCI
|
5R01CA127238-02
|
|
Herpesvirus-induced telomerase dysregulation and tumor formation
|
OSTERRIEDER, NIKOLAUS
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$228,723
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R01DA016993-05
|
|
HIV/STI Prevention for Drug-Involved Couples
|
GILBERT, LOUISA
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$876,617
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI067913-03
|
|
Spatial Epidemiology of Syphilis and Gonorrhea in North Carolina
|
MILLER, WILLIAM
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$345,404
|
|
Sexually Transmitted Diseases/Herpes
|
NIAID
|
5R01AI063940-05
|
|
Antigenic variation of TprK
|
LUKEHART, SHEILA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$282,026
|
|
Sexually Transmitted Diseases/Herpes
|
NIDA
|
5R01DA019405-03
|
|
Drug Choice, Impulsivity, and Risky Sexual Behavior
|
LEJUEZ, CARL
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$295,996
|
|
